SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 190 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,620,000 | +22.7% | 103,810 | -25.7% | 0.14% | +6.1% |
| Q3 2020 | $1,320,000 | -0.2% | 139,760 | -5.4% | 0.13% | +1.6% |
| Q2 2020 | $1,323,000 | +20.6% | 147,720 | -14.2% | 0.13% | +4.9% |
| Q1 2020 | $1,097,000 | -23.8% | 172,160 | 0.0% | 0.12% | -10.2% |
| Q4 2019 | $1,440,000 | -16.0% | 172,160 | -9.1% | 0.14% | -20.8% |
| Q3 2019 | $1,714,000 | -16.0% | 189,360 | 0.0% | 0.17% | +13.1% |
| Q2 2019 | $2,040,000 | – | 189,360 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
| Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
| Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
| WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
| Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
| EMC Capital Management | 48,992 | $765,000 | 0.58% |
| Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
| Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
| Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |